Clinical Trial Update: Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 trial compared melatonin to placebo to aid benzodiazepine discontinuation in patients with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Lone Baandrup | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED